Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT03563651
Eligibility Criteria:
Inclusion Criteria:
* All patients with metastatic/unresectable colorectal cancer who will undergo first, second, or third line therapy; the participating investigator will select treatment, however, patients with Kras wild type must receive anti-EGFR therapy to be eligible for this study
* Subject consent to enrollment on the protocol
* Histologically confirmed metastatic or un-resectable colorectal cancer, known Kras status; knowledge of other mutations is optional
* Willingness to undergo biopsy at the time of progression
* Willingness to follow the study instructions for collection of specimens
* Available archival tissue
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03563651
Study Brief:
Protocol Section:
NCT03563651